For the quarter ending 2026-03-31, TNXP had -$23,799K decrease in cash & cash equivalents over the period. -$44,010K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net loss | -40,194 | -46,910 | -77,111 |
| Depreciation and amortization | 555 | 488 | 1,437 |
| Loss on note | - | 0 | -1,159 |
| Loss on extinguishment of debt | 0 | 0 | -2,092 |
| Bad debt expense | - | 0 | 31 |
| Issuance costs of derivative instrument | - | 0 | 1,837 |
| Inventory write-off | - | -649 | 1,318 |
| Amortization of debt discounts | - | 0 | 65 |
| Stock-based compensation | 1,970 | 1,789 | 4,228 |
| Accounts receivable, net | 2,548 | 2,789 | -170 |
| Prepaid expenses and other | 278 | 1,002 | 2,159 |
| Other non-current assets | 3,742 | - | - |
| Inventory | -2,369 | -364 | -1,362 |
| Accounts payable | 1,533 | -738 | 3,732 |
| Operating lease liabilities and rou asset, net | 80 | -285 | -18 |
| Accrued expenses and other current liabilities | -2,063 | 10,082 | 1,663 |
| Net cash used in operating activities | -42,318 | -39,650 | -60,194 |
| Issuance of note | - | 0 | 2,012 |
| Proceeds from note | - | 853 | - |
| Purchase of property and equipment | 1,692 | 1,874 | 1,495 |
| Net cash used in investing activities | -1,692 | -1,021 | -3,507 |
| Repurchase of common stock, net of 30 expenses | - | 7,811 | 5,949 |
| Repayments of term loan | - | 0 | 9,650 |
| Proceeds from espp | 79 | - | - |
| Proceeds, net issuance costs paid of 676 and 2,270, from sale of common stock | 20,126 | 66,954 | 170,986 |
| Net cash provided by financing activities | 20,205 | 59,143 | 155,387 |
| Effect of currency rate change on cash | 6 | -14 | -17 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -23,799 | 18,458 | 91,669 |
| Cash, cash equivalents and restricted cash beginning of the period | 209,807 | 191,349 | 99,680 |
| Cash, cash equivalents and restricted cash end of period | 186,008 | 209,807 | 191,349 |
Tonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. (TNXP)